Mateon Therapeutics Inc (OTCQB:MATN)

Delayed Data
As of 2:27pm ET
 -0.0129 / -5.54%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Mateon Therapeutics Inc have a median target of 0.55, with a high estimate of 0.55 and a low estimate of 0.55. The median estimate represents a +150.00% increase from the last price of 0.22.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Mateon Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -66.67%
Growthannually 65.38%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.